JAMA子刊:非侵入性脑刺激干预对精神分裂症阴性症状的影响

2022-06-29 MedSci原创 MedSci原创

左背外侧前额叶皮层的兴奋性NIBS方案与消极症状严重程度的明显大的改善有关。

精神分裂症阴性症状对患者的功能结果和生活质量有不利的影响,而且很少有治疗方案被认为对这一症状层面有效。研究表明,无创脑刺激(NIBS)干预措施可能对治疗消极症状有效。然而,不同的NIBS方案对缓解消极症状的疗效比较仍不清楚。

为了比较不同NIBS干预措施对治疗消极症状的疗效和可接受性,来自我国台湾的学者开展了一项meta分析。对ClinicalKey、Cochrane CENTRAL、Embase、ProQuest、PubMed、ScienceDirect、ClinicalTrials.gov和Web of Science等电子数据库进行系统性检索。

该网络荟萃分析以评估评价重复经颅磁刺激(rTMS)、θ-突发刺激、经颅随机噪声刺激、经皮迷走神经刺激和经颅直流电刺激对精神分裂症阴性症状疗效的试验结果的汇总。研究对精神分裂症患者进行NIBS干预的随机临床试验(RCTs)被包括在内。

结果涉及2211名参与者(平均[范围]年龄,38.7[24.0-57.0]岁;女性患者的平均[范围]比例,30.6%[0%-70.0%])的48项RCT被纳入。与假对照干预相比,兴奋性NIBS策略(差异[SMD]:高清晰度经颅随机噪声刺激,-2.19[95%CI,-3.36至-1.02];间歇性θ爆发刺激,-1.32[95%CI,-1.88至-0.76];正极经颅直接电流刺激,-1.28[95%CI,-2.55至-0. 02];高频经颅磁刺激,-0.43[95%CI,-0.68至-0.18];极端高频经颅磁刺激,-0.45[95%CI,-0.79至-0.12])在左背外侧前额叶皮层上进行或不进行大脑对侧区域的其他抑制性刺激方案,与消极症状的明显减少有关。各组之间的可接受性没有明显差异。

综上,在这个网络荟萃分析中,左背外侧前额叶皮层的兴奋性NIBS方案与消极症状严重程度的明显大的改善有关。

 

参考文献:

Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia: A Systematic Review and Network Meta-analysis . JAMA Psychiatry. Published online June 22, 2022. doi:10.1001/jamapsychiatry.2022.1513

评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1650656, encodeId=7c8d1650656f0, content=<a href='/topic/show?id=bd709e53325' target=_blank style='color:#2F92EE;'>#阴性症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97533, encryptionId=bd709e53325, topicName=阴性症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5cd24069291, createdName=swallow, createdTime=Sat Jun 03 10:37:36 CST 2023, time=2023-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034710, encodeId=6c562034e1026, content=<a href='/topic/show?id=cf91992e053' target=_blank style='color:#2F92EE;'>#非侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99270, encryptionId=cf91992e053, topicName=非侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Tue Aug 09 17:37:36 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404181, encodeId=0f31140418181, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457688, encodeId=bd3a145e68839, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028831, encodeId=0c9d202883129, content=<a href='/topic/show?id=b1e1269e5c6' target=_blank style='color:#2F92EE;'>#侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26975, encryptionId=b1e1269e5c6, topicName=侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Thu Nov 10 22:37:36 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243582, encodeId=9170124358242, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Sat Jun 25 19:37:36 CST 2022, time=2022-06-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1650656, encodeId=7c8d1650656f0, content=<a href='/topic/show?id=bd709e53325' target=_blank style='color:#2F92EE;'>#阴性症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97533, encryptionId=bd709e53325, topicName=阴性症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5cd24069291, createdName=swallow, createdTime=Sat Jun 03 10:37:36 CST 2023, time=2023-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034710, encodeId=6c562034e1026, content=<a href='/topic/show?id=cf91992e053' target=_blank style='color:#2F92EE;'>#非侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99270, encryptionId=cf91992e053, topicName=非侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Tue Aug 09 17:37:36 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404181, encodeId=0f31140418181, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457688, encodeId=bd3a145e68839, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028831, encodeId=0c9d202883129, content=<a href='/topic/show?id=b1e1269e5c6' target=_blank style='color:#2F92EE;'>#侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26975, encryptionId=b1e1269e5c6, topicName=侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Thu Nov 10 22:37:36 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243582, encodeId=9170124358242, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Sat Jun 25 19:37:36 CST 2022, time=2022-06-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1650656, encodeId=7c8d1650656f0, content=<a href='/topic/show?id=bd709e53325' target=_blank style='color:#2F92EE;'>#阴性症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97533, encryptionId=bd709e53325, topicName=阴性症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5cd24069291, createdName=swallow, createdTime=Sat Jun 03 10:37:36 CST 2023, time=2023-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034710, encodeId=6c562034e1026, content=<a href='/topic/show?id=cf91992e053' target=_blank style='color:#2F92EE;'>#非侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99270, encryptionId=cf91992e053, topicName=非侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Tue Aug 09 17:37:36 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404181, encodeId=0f31140418181, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457688, encodeId=bd3a145e68839, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028831, encodeId=0c9d202883129, content=<a href='/topic/show?id=b1e1269e5c6' target=_blank style='color:#2F92EE;'>#侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26975, encryptionId=b1e1269e5c6, topicName=侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Thu Nov 10 22:37:36 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243582, encodeId=9170124358242, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Sat Jun 25 19:37:36 CST 2022, time=2022-06-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1650656, encodeId=7c8d1650656f0, content=<a href='/topic/show?id=bd709e53325' target=_blank style='color:#2F92EE;'>#阴性症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97533, encryptionId=bd709e53325, topicName=阴性症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5cd24069291, createdName=swallow, createdTime=Sat Jun 03 10:37:36 CST 2023, time=2023-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034710, encodeId=6c562034e1026, content=<a href='/topic/show?id=cf91992e053' target=_blank style='color:#2F92EE;'>#非侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99270, encryptionId=cf91992e053, topicName=非侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Tue Aug 09 17:37:36 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404181, encodeId=0f31140418181, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457688, encodeId=bd3a145e68839, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028831, encodeId=0c9d202883129, content=<a href='/topic/show?id=b1e1269e5c6' target=_blank style='color:#2F92EE;'>#侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26975, encryptionId=b1e1269e5c6, topicName=侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Thu Nov 10 22:37:36 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243582, encodeId=9170124358242, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Sat Jun 25 19:37:36 CST 2022, time=2022-06-25, status=1, ipAttribution=)]
    2022-06-27 amyloid
  5. [GetPortalCommentsPageByObjectIdResponse(id=1650656, encodeId=7c8d1650656f0, content=<a href='/topic/show?id=bd709e53325' target=_blank style='color:#2F92EE;'>#阴性症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97533, encryptionId=bd709e53325, topicName=阴性症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5cd24069291, createdName=swallow, createdTime=Sat Jun 03 10:37:36 CST 2023, time=2023-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034710, encodeId=6c562034e1026, content=<a href='/topic/show?id=cf91992e053' target=_blank style='color:#2F92EE;'>#非侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99270, encryptionId=cf91992e053, topicName=非侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Tue Aug 09 17:37:36 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404181, encodeId=0f31140418181, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457688, encodeId=bd3a145e68839, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028831, encodeId=0c9d202883129, content=<a href='/topic/show?id=b1e1269e5c6' target=_blank style='color:#2F92EE;'>#侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26975, encryptionId=b1e1269e5c6, topicName=侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Thu Nov 10 22:37:36 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243582, encodeId=9170124358242, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Sat Jun 25 19:37:36 CST 2022, time=2022-06-25, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1650656, encodeId=7c8d1650656f0, content=<a href='/topic/show?id=bd709e53325' target=_blank style='color:#2F92EE;'>#阴性症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97533, encryptionId=bd709e53325, topicName=阴性症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5cd24069291, createdName=swallow, createdTime=Sat Jun 03 10:37:36 CST 2023, time=2023-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034710, encodeId=6c562034e1026, content=<a href='/topic/show?id=cf91992e053' target=_blank style='color:#2F92EE;'>#非侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99270, encryptionId=cf91992e053, topicName=非侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Tue Aug 09 17:37:36 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404181, encodeId=0f31140418181, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76493, encryptionId=7366e6493be, topicName=精神分裂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457688, encodeId=bd3a145e68839, content=<a href='/topic/show?id=f9f684e27d6' target=_blank style='color:#2F92EE;'>#脑刺激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84727, encryptionId=f9f684e27d6, topicName=脑刺激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4c5968615, createdName=amyloid, createdTime=Mon Jun 27 07:37:36 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028831, encodeId=0c9d202883129, content=<a href='/topic/show?id=b1e1269e5c6' target=_blank style='color:#2F92EE;'>#侵入性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26975, encryptionId=b1e1269e5c6, topicName=侵入性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Thu Nov 10 22:37:36 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243582, encodeId=9170124358242, content=JAMA上文章都是顶级的,谢谢梅斯及时上新, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=肿瘤克星, createdTime=Sat Jun 25 19:37:36 CST 2022, time=2022-06-25, status=1, ipAttribution=)]
    2022-06-25 肿瘤克星

    JAMA上文章都是顶级的,谢谢梅斯及时上新

    0

相关资讯

Human Brain Mapping:首发未治疗精神分裂症患者伴听觉言语幻觉的颞叶、额叶皮质和丘脑存在半球间和半球内功能连接动态学异常

精神分裂症AVHs患者半球间和半球内dFCD的异常时间变异性主要集中在作为听觉和语言通路关键组成部分的颞叶、额叶皮质和丘脑。

JAMA子刊:炎症可能通过激活小胶质细胞和/或星形细胞功能障碍导致大脑结构的变化

由基因决定的IL-6与大脑结构有关,并可能影响发育期神经精神疾病(包括精神分裂症和自闭症)所涉及的区域。

JAHA:精神分裂症、分裂情感障碍或双相情感障碍患者的心血管风险

近日,心血管疾病领域权威杂志JAHA上发表了一篇研究文章,研究人员旨在比较伴有和不伴有严重精神疾病(SMI;双相情感障碍、精神分裂症或分裂情感障碍)患者估计的10年和30年心血管风险。

Lancet Psychiatry:50年的研究数据——精神分裂症患者教育程度正在改善!

精神分裂症患者在教育程度方面持续面临不平等

AP&T:精神分裂症和新发炎症性肠病的风险

精神分裂症是一种思想方式、语言观点、情绪、自我认知和行为表现能力出现异常的慢性且严重的精神疾病,在全球范围内影响着超过2000万人,患者早年死亡率相较普通人可能高出2-3倍。

Infection:戊型肝炎病毒感染与精神分裂症的发生之间没有相关性

戊型肝炎多数病例症状较轻,黄疸不很严重。治疗 适当休息、合理营养为主,选择性使用药物为辅。

拓展阅读

常见抗精神病药引起体重增加的风险及治疗对策

中国超 640 万精神分裂症患者,常用抗精分药易致体重增加,增加代谢疾病风险且影响治疗依从性。其机制与神经递质受体作用相关,治疗策略包括换药、联用二甲双胍或 GLP-1 激动剂等。

不同剂量精神类药物对精分患者死亡率的影响

该研究结果显示,控制 ITB 后,高剂量抗精神病药增加死亡率,高剂量抗抑郁药降低死亡率,苯二氮卓类药物增加死亡率,研究强调控制 ITB 的重要性。

Schizophrenia:D-氨基酸氧化酶抑制剂对精神分裂症患者症状和认知功能影响的Meta分析

D-氨基酸氧化酶抑制剂(DAOI)显著改善精神分裂症患者的临床症状和认知功能。苯甲酸钠的效果优于luvadaxistat,且女性患者认知改善更明显。然而,研究样本量小、异质性高,需进一步验证。

单用VS联用:一文汇总抗精神病药物的临床治疗现状

全球超 2400 万人患精神分裂症,约 30% 患者单药治疗不佳。临床抗精神病药联用普遍,虽可提升疗效、降低复发风险,但不良反应风险也增加,使用时需精准评估风险获益比。

从眼动到基因表达:我国学者揭示首次发作精神分裂症和临床高风险个体的神经生物学机制

FSZ患者表现出广泛的眼动异常和右侧中扣带回、颞极ReHo升高,CHR个体则表现为左侧颞中回和颞上回ReHo升高。机器学习分类准确率高达94%,基因分析揭示突触相关通路异常。

Epidemiology and Psychiatric Sciences:严重精神障碍患者的孤独感与社会隔离患病率

严重精神障碍患者中孤独感患病率为59.1%,精神分裂症谱系障碍患者的社会隔离患病率达63.0%。亚洲地区孤独感患病率显著高于北美,且抑郁症状与生活质量低下是其重要关联因素。